Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache (NCT05452239)
20007A
This trial is No longer recruiting
Registration number NCT05452239
Program & service
This trial is being run with the Brain service, and as part of the Neurology program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Elspeth Hutton
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR